- PLN212.92m
- PLN295.83m
- PLN42.01m
Brief: Synthaverse To Increase Share Capital Via Issue Of W Series Shares
Brief: Synthaverse Appoints Artur Chodkowski As Vice President
Brief: Synthaverse Says Unisono Capital Divests Its Stake In Company
Brief: Synthaverse Plans To Raise 23 Mln Zlotys Via Share Issue
Brief: Synthaverse To Update And Internationalize Development Strategy
Brief: Synthaverse Says CoraPharm Gets Marketing Authorization For Onko BCG In Bosnia and Herzegovina
Brief: Synthaverse AGM To Vote On No FY Dividend
Brief: Synthaverse Q1 Net Loss At 0.5 Mln Zlotys
Brief: Synthaverse FY Net Profit At 7.6 Mln Zlotys
Brief: Synthaverse Signs Agreements With Blau Farmacéutica Worth 168.9 Mln Zlotys
Brief: Synthaverse Signs Deal With Biodrug For Min. Eur 5.6 Mln P.A.
Brief: Synthaverse Q3 Net Loss 0.4 Mln Zlotys
Brief: Synthaverse H1 Net Profit At 1.0 Mln Zlotys
Brief: Synthaverse Says Drug Onko BCG Gets Registered On Territory Of France
Brief: Synthaverse BCG 10 Anti-Tuberculosis Vaccine Chosen In Tender By Minister Of Health
Brief: Synthaverse AGM To Vote On Retaining FY 2023 Net Profit
Brief: Synthaverse Q1 Net Result Turns To Loss Of 0.4 Mln Zlotys
Brief: Synthaverse Signs License Deal For Davoster Medical Product
Brief: Synthaverse FY Net Profit Down At 4.8 Mln Zlotys